A single AAV injection corrected progeria mutations in mouse bone — timing was everything

Key Findings

🦠 Compressing 10 Years of Cervical Cancer Into 6 Months

• A CRISPR screen in HPV-positive pre-tumor organoids identified NF1 — a RAS pathway brake — as the top suppressor of malignant transformation. Knocking it out accelerated carcinogenesis from a decade-long process into 3–6 months in lab organoids.
• Researchers then designed a small NF1-mimicking peptide using AI modeling. In HPV-driven mouse models, it reduced tumor burden and restored local immune activity without triggering systemic immune activation.

🧠 A CRISPR Screen Maps the Immune State That Shapes Brain Disease

• A genome-wide CRISPR interference screen in human stem cell-derived microglia identified 772 genes that regulate the interferon-responsive microglial state — a brain immune activation pattern linked to aging, neurodegeneration, and synaptic pruning.
• Among the surprises: CNOT10, a subunit of an RNA-degradation complex, turned up as a previously unrecognized regulator of this state. The dataset is now a searchable resource for anyone studying microglial biology.

❤️ Classifying Thousands of Heart Disease Variants at Once

• Most variants in the LDL receptor gene — the most common genetic cause of familial high cholesterol — sit in clinical limbo with no clear pathogenic classification. A prime editing screen systematically tested large numbers of these variants simultaneously, using activity normalization to distinguish harmful from benign changes.
• Early classification means earlier treatment and earlier cascade testing for at-risk family members, two things that currently lag for most patients.

🔬 Turning Glioblastoma Cells Into Their Own Immune Recruiters

• Glioblastoma evades immunotherapy partly because tumor cells present antigens poorly. A CRISPRa screen identified four transcription factors that, when activated together, convert glioblastoma cells into dendritic cell-like cells capable of triggering immune responses.
• In multiple mouse models, reprogrammed tumor cells reshaped the tumor microenvironment and produced durable antitumor immunity. The effect was synergistic with checkpoint inhibitor drugs, and the approach was tested in a humanized model using cells from actual GBM patients.

🛡️ How Resistance Plasmids Survive CRISPR Immunity in Bacteria

• Carbapenem-resistant Klebsiella pneumoniae — one of the most dangerous drug-resistant pathogens in hospitals — carries plasmids that persist even when the bacterium has its own CRISPR defenses. A protein called AcrIE10, encoded by those plasmids, does two things at once: it blocks the bacterial CRISPR machinery and self-regulates its own expression to avoid overproduction.
• The dual function creates a stable equilibrium between host immunity and plasmid survival, explaining why these resistance elements are so hard to dislodge.

🩸 A Skin Cell Test for a Rare Immune Deficiency

• NHEJ1 mutations cause a form of severe combined immunodeficiency where patients are also hypersensitive to radiation — a combination that makes standard bone marrow transplant conditioning dangerous. Researchers used base editing to reverse NHEJ1 mutations directly in patient fibroblasts, restoring normal radiation sensitivity in those cells.
• The work is a proof of concept in patient-derived cells, not yet a therapy, but it demonstrates that base editing can interrogate specific variants and potentially correct the underlying defect.